Humana Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 54 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 285.97.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Humana Inc is 4.87, ranking 73 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 32.65B, representing a year-over-year increase of 11.06%, while its net profit experienced a year-over-year increase of 59.38%.
Key Metrics
The current valuation score of Humana Inc is 6.75, ranking 45 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 18.09, which is 67.41% below the recent high of 30.28 and 13.05% above the recent low of 15.73.
The current earnings forecast score of Humana Inc is 6.76, ranking 51 out of 75 in the Healthcare Providers & Services industry. The average price target is 289.00, with a high of 353.33 and a low of 215.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Humana Inc is 6.21, ranking 63 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 257.70 and the support level at 158.09, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Humana Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 100.03%, representing a quarter-over-quarter decrease of 1.50%. The largest institutional shareholder is The Vanguard, holding a total of 14.20M shares, representing 11.81% of shares outstanding, with 2.39% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Humana Inc is 6.84, ranking 24 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.44. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Humana Inc’s latest ESG disclosure leads the Healthcare Providers & Services industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
